Product image of Mcp (Metoclopramide) supplied by GNH India

Mcp

Active Ingredient:
Metoclopramide
Origin:
EU

Mcp (Metoclopramide)

Metoclopramide, the active ingredient in Mcp, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It treats nausea and vomiting, gastroparesis and gastroesophageal reflux disease in adult patients.

GNH India supplies Mcp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch, ensuring reliable access for healthcare providers across multiple regions. Our distribution network includes major hospital systems, community pharmacies and specialty clinics, facilitating timely delivery and support.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metoclopramide is used to manage conditions involving nausea, vomiting and impaired gastrointestinal motility.
  • Nausea and vomiting: reduces episodes by blocking dopamine receptors in the chemoreceptor trigger zone, improving comfort in adults.
  • Gastroparesis: enhances gastric emptying by increasing gastrointestinal motility, helping patients achieve better nutrient absorption.
  • Gastroesophageal reflux disease: alleviates reflux symptoms through prokinetic action, decreasing acid exposure in the esophagus.

How It Works

  • Metoclopramide antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, diminishing the vomiting reflex. It also blocks 5‑HT3 receptors and stimulates 5‑HT4 receptors, which together promote coordinated gastrointestinal smooth‑muscle contractions, accelerating gastric emptying and intestinal transit. The drug crosses the blood‑brain barrier, allowing central D2 antagonism, while peripheral actions on serotonin receptors enhance motility of the upper gastrointestinal tract.

Side Effects

Metoclopramide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Drowsiness: mild sedation or fatigue.
  • Diarrhea: loose stools or increased bowel movements.
  • Restlessness: feeling of inner tension or agitation.
  • Headache: mild to moderate head pain.

Serious or Rare Side Effects

  • Extrapyramidal symptoms: muscle rigidity, tremor or dystonia, especially with high doses.
  • Tardive dyskinesia: irreversible involuntary movements with prolonged use.
  • Neuroleptic malignant syndrome: rare life‑threatening condition with fever and muscle rigidity.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.

Precautions & Warnings

Before prescribing Metoclopramide, clinicians should consider several safety precautions.

  • Assess renal function: dose adjustment may be needed in patients with renal impairment.
  • Limit duration: avoid use beyond 12 weeks to reduce risk of tardive dyskinesia.
  • Monitor for depression: watch for worsening mood or suicidal thoughts.
  • Avoid in patients with gastrointestinal obstruction: drug may exacerbate blockage.
  • Caution in the elderly: increased susceptibility to central nervous system side effects.
  • Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Metoclopramide can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Anticholinergic agents: may reduce prokinetic effect and increase anticholinergic side effects.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can raise metoclopramide plasma levels, increasing toxicity risk.
  • Dopamine antagonists (e.g., antipsychotics): additive central nervous system depression.

Moderate Interactions (Monitor Closely)

  • Serotonergic drugs (e.g., ondansetron, SSRIs): risk of serotonin syndrome.
  • Opioids: may enhance gastrointestinal side effects such as constipation.
  • Alcohol: can increase drowsiness and dizziness.

Frequently Asked Questions

Metoclopramide is prescribed to treat nausea and vomiting, to improve gastric emptying in gastroparesis, and to relieve symptoms of gastroesophageal reflux disease by enhancing gastrointestinal motility.

The drug blocks dopamine D2 receptors in the brain’s chemoreceptor trigger zone, reducing the vomiting reflex, while also antagonizing 5‑HT3 and stimulating 5‑HT4 receptors to promote coordinated smooth‑muscle activity in the gut, thereby speeding gastric emptying.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, age, renal function and other factors. Dosage regimens vary, and the prescriber will tailor the schedule to achieve the desired therapeutic effect.

Safety data are limited; Metoclopramide should be used during pregnancy or lactation only if the potential benefit justifies any potential risk to the fetus or infant. The prescriber will evaluate the risk‑benefit profile for each individual.

To request Mcp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide and other prokinetic agents such as domperidone share anti‑nausea and motility‑enhancing properties, but Metoclopramide also blocks central dopamine receptors, giving it stronger antiemetic activity. However, it carries a higher risk of extrapyramidal side effects, which may influence the choice of therapy.

Mcp should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Mcp is supplied as oral tablets that should be swallowed whole with a glass of water. It can be taken with or without food, unless otherwise directed by the prescriber, and the dosing interval is set by the treating physician.

Serious adverse reactions include extrapyramidal symptoms such as dystonia or akathisia, tardive dyskinesia with long‑term use, and rare but life‑threatening neuroleptic malignant syndrome. Patients should be instructed to seek immediate medical attention if they experience muscle rigidity, high fever, or uncontrolled movements.

Metoclopramide is contraindicated in individuals with known hypersensitivity to the drug, those with gastrointestinal obstruction, perforation, or hemorrhage, and patients with pheochromocytoma. Caution is also advised for patients with severe renal impairment, epilepsy, or a history of movement disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoclopramide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT